Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

BVMF:ONCO3 Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	112	509.55	550.74	550.7	263.21	536.84
Short-Term Investments	1	0.74	1,338	210.72	829.59	-
Trading Asset Securities	-	2.43	32.19	-	-	1,478
Cash & Short-Term Investments	113	512.71	1,921	761.42	1,093	2,015
Cash Growth	-88.38%	-73.30%	152.23%	-30.32%	-45.76%	155.97%
Accounts Receivable	1,421	1,490	2,049	1,857	1,380	666.15
Other Receivables	304	238.67	279.78	190.72	142.6	47.78
Receivables	1,725	1,729	2,329	2,048	1,522	713.93
Inventory	205	185.48	225.24	206.39	163.94	69.41
Other Current Assets	537	469.39	186.19	89.69	47.87	73.13
Total Current Assets	2,612	2,896	4,661	3,105	2,827	2,871
Property, Plant & Equipment	985	1,103	1,336	1,235	1,091	727.55
Long-Term Investments	33	85.89	179.9	143.16	34.37	37.27
Goodwill	-	1,439	2,405	2,670	2,569	1,169
Other Intangible Assets	2,600	1,244	1,346	1,521	1,345	1,069
Long-Term Accounts Receivable	-	-	385.58	-	-	-
Long-Term Deferred Tax Assets	188	159.39	508.09	392.58	223.43	33.42
Other Long-Term Assets	134	157.95	360.97	106.28	97.78	93.22
Total Assets	6,604	7,131	11,202	9,181	8,220	6,032

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,427	1,097	1,020	795.4	604.79	427.34
Accrued Expenses	287	204.24	333.01	219.04	200.82	149.04
Current Portion of Long-Term Debt	3,386	3,232	756.26	407.03	349.97	358.47
Current Portion of Leases	53	48	57.83	67.22	64.17	37.47
Current Income Taxes Payable	72	46.62	54.75	62.25	4.55	19.87
Other Current Liabilities	668	573.91	231.83	265.52	658.99	198.54
Total Current Liabilities	5,893	5,202	2,453	1,816	1,883	1,191
Long-Term Debt	-	109.34	4,276	3,750	2,769	1,810
Long-Term Leases	378	464.98	503.37	345.13	304.66	232.2
Long-Term Deferred Tax Liabilities	59	74.67	41.19	21.64	6.39	5.94
Other Long-Term Liabilities	176	217.18	546.32	568.47	623.91	488.69
Total Liabilities	6,506	6,068	7,820	6,502	5,587	3,727

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4,568	4,562	3,147	2,455	2,250	2,207
Retained Earnings	-5,229	-4,335	-711.06	-64.87	-288.49	-334.75
Treasury Stock	-83	-87.57	-94.47	-103.7	-79.4	-20.62
Comprehensive Income & Other	760	761.78	804.86	15.09	235.96	2.25
Total Common Equity	16	900.93	3,146	2,301	2,118	1,854
Minority Interest	82	161.48	236.08	378.15	514.67	450.93
Shareholders' Equity	98	1,062	3,382	2,679	2,632	2,305
Total Liabilities & Equity	6,604	7,131	11,202	9,181	8,220	6,032

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3,817	3,854	5,593	4,569	3,488	2,438
Net Cash (Debt)	-3,688	-3,342	-3,673	-3,808	-2,395	-423.3
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.30	-3.86	-5.96	-7.11	-4.50	-1.03
Filing Date Shares Outstanding	1,118	1,118	632.79	508.28	478.21	474.78
Total Common Shares Outstanding	1,118	1,118	632.79	508.28	478.21	474.78
Working Capital	-3,281	-2,306	2,208	1,289	943.55	1,681
Book Value Per Share	0.01	0.81	4.97	4.53	4.43	3.90
Tangible Book Value	-2,584	-1,781	-604.17	-1,889	-1,797	-384.4
Tangible Book Value Per Share	-2.31	-1.59	-0.95	-3.72	-3.76	-0.81
Land	-	5.22	-	-	-	-
Machinery	-	522.23	-	-	-	-
Construction In Progress	-	113.21	-	-	-	-
Leasehold Improvements	-	568.59	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error